Test Price
1,600 AED✅ Home Collection Available
QF-PCR Panel (13,18,21,XY) + Karyotyping Test in UAE | AED 1,600 | DHA Licensed
Executive Summary & Core Metrics
Exclusive Prenatal Genetic Diagnostic Solution. Our comprehensive test combines rapid QF-PCR for common aneuploidies (trisomies 13, 18, 21, and sex chromosome anomalies) with gold-standard G-banding karyotyping. Delivered under strict DHA protocols, this dual-methodology approach provides 99.9% diagnostic sensitivity via ISO 9001:2015-accredited laboratory processes (Cert: INT/EGQ/2509DA/3139). Sample Collection: Hospital extraction only – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for optimal safety. Clinical Oversight: Results interpreted and reported by Consultant Medical Geneticist Dr. Lina Osama Zaki Quteineh (DHA ID: 9294403). Direct billing and insurance verification available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Quantitative Fluorescence Polymerase Chain Reaction (QF-PCR) provides rapid preliminary results within 1–2 days, while conventional G-banding karyotyping comprehensively analyzes all 46 chromosomes within 12–15 days. This integrated strategy ensures both rapid clinical decision-making and complete genetic insight, recommended by DHA guidelines for high-risk pregnancies, advanced maternal age, abnormal ultrasound markers, or parental chromosomal concerns.
| Feature | Our Test: QF-PCR + Karyotyping | Alternative: QF-PCR Alone |
|---|---|---|
| Method | Quantitative Fluorescence PCR + G-banding Karyotyping | Quantitative Fluorescence PCR only |
| Detection Scope | Trisomies 13, 18, 21, X/Y aneuploidies + all structural/numerical chromosome abnormalities | Only common aneuploidies (13, 18, 21, X, Y) |
| Turnaround Time | QF-PCR: 1–2 days; Karyotype: 12–15 days | 1–2 days |
| Accuracy | >99.9% for targeted aneuploidies; gold-standard full karyotype | >99% for targeted aneuploidies only |
| DHA Compliance | Fully compliant with DHA prenatal screening and diagnostic protocols | Limited – incomplete genetic analysis may miss clinically significant abnormalities |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I emphasize that this combined QF-PCR and karyotyping approach offers parents the dual advantage of speed and completeness. The rapid QF-PCR result alleviates immediate anxiety regarding common trisomies, while the comprehensive karyotype provides a definitive genetic blueprint. Every result is meticulously reviewed in the context of the patient's clinical history and ultrasound findings, ensuring informed and compassionate counseling."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication & Clinical Advisory
⚠️ Important Advisory: Do not alter or discontinue any prescribed medications or supplements without direct consultation with your treating physician. Genetic test results are intended to augment, not replace, ongoing clinical management and prenatal care protocols.
Safety Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Active vaginal bleeding, suspected intra-amniotic infection, severe oligohydramnios, uncorrected coagulopathy, or inability to visualize a safe needle path. Invasive sampling is strictly deferred if any of these contraindications are present.
- Post-Procedure Emergency Signs: Heavy vaginal bleeding (soaking a pad per hour), high fever (>38.5°C), severe or worsening abdominal pain, leaking of amniotic fluid, or regular painful contractions. Seek immediate emergency care at the nearest DHA-licensed hospital if any of these symptoms occur.
Patient FAQ & Clinical Guidance
1. What is the QF-PCR Panel + Karyotyping test?
This is a comprehensive prenatal diagnostic test that combines two advanced genetic techniques. QF-PCR rapidly screens for the most common chromosomal aneuploidies (trisomies 13, 18, 21, and sex chromosome X/Y anomalies), providing results in 1–2 days. The concurrent karyotyping analyzes the full set of 46 chromosomes to detect any numerical or large structural abnormalities, providing a complete genetic picture within 12–15 days. This dual approach is the gold standard for definitive prenatal diagnosis in the UAE.
2. How long does it take to get results?
The preliminary QF-PCR report is available within 1–2 business days of sample receipt. The final, comprehensive karyotype report, which requires cell culture and meticulous G-banding analysis, is completed within 12–15 business days. Both reports are carefully reviewed and signed by Dr. Lina Osama Zaki Quteineh, ensuring the highest level of clinical accuracy and interpretive insight.
3. Is the procedure safe for my baby and me?
While amniocentesis and chorionic villus sampling (CVS) carry inherent procedural risks, our DHA-licensed specialists utilize ISO-certified techniques under continuous ultrasound guidance, minimizing the procedure-related risk of miscarriage to less than 0.2%. Patient safety protocols strictly adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Given the high diagnostic yield, the benefits of accurate genetic diagnosis typically far outweigh the minimal procedural risks for high-risk pregnancies.
4. What is the cost of the test, and how can I book it?
The total price for the combined QF-PCR Panel and Karyotyping test is AED 1,600. This includes the laboratory analysis, comprehensive clinical reporting, and post-test telephonic genetic counseling. To book your appointment or for direct insurance billing verification, please contact our patient coordination team via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Your Trust & Legal Compliance
DNA Labs UAE operates under the strict regulatory oversight of the Dubai Health Authority (DHA) and fully complies with the UAE federal legal framework for health data and patient safety:
- Data Privacy: All patient data is processed and stored in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring the highest standards of confidentiality and data security.
- Health Information Governance: Our digital health infrastructure complies with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability & Safety: Clinical protocols and patient safety measures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Accreditation: Our laboratory processes are ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | QF-PCR Panel (13,18,21,XY) + Karyotyping |
| Price (AED) | 1,600 |
| Turnaround Time | QF-PCR: 1-2 Days / Karyotyping: 12-15 Days |
| Sample Type / Matrix | Amniotic Fluid, Chorionic Villi, or Cord Blood (Hospital Extraction Only) |
| Methodology Used | Quantitative Fluorescence Polymerase Chain Reaction (QF-PCR) + G-banding Karyotyping |
| ICD-10-CM Code | Z36.89, O35.1 |
| LOINC Code | 81349-0 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians